Novartis India Ltd. reported standalone unaudited earnings results for the second quarter and six months ended September 30, 2016. For the quarter, the company reported sales/income from operations of INR 1,625.6 million against INR 2,150.4 million for the same period previous year. Profit from operations before other income and finance costs was INR 147.5 million against INR 104.1 million for the same period of previous year. Profit before tax was INR 338.6 million against INR 1,396.6 million for the same period of previous year. Net profit was INR 222.1 million or INR 7.03 per basic and diluted share compared to INR 1,036.9 million or INR 32.45 per diluted share for the same period of previous year. For the six months, the company reported sales/income from operations of INR 3,211.8 million against INR 4,298.7 million for the same period previous year. Profit from operations before other income and finance costs was INR 232.9 million against INR 104.3 million for the same period of previous year. Profit before tax was INR 635.8 million against INR 1,600.3 million for the same period of previous year. Net profit was INR 412.8 million or INR 13.00 per basic and diluted share compared to INR 1,170.3 million or INR 36.62 per diluted share for the same period of previous year.